Capecitabine in Women With Operable Breast Cancer
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Invasive Breast Carcinoma|Primary Invasive Breast Cancer|Stage I Breast Cancer|Stage II Breast Cancer|Stage III Breast Cancer
Interventions: DRUG: Capecitabine
Sponsor: Dana-Farber Cancer Institute
Collaborators: Hoffmann-La Roche|Beth Israel Deaconess Medical Center|Brigham and Women's Hospital